Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FEMOSEAL CLOSE - Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study

NCT05027698 is registered in ClinicalTrials.gov with Terumo Europe N.V. as lead sponsor.

NCT NCT05027698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05027698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FEMOSEAL CLOSE - Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study
Lead sponsor
Terumo Europe N.V.
Phase
Observational
Overall status
Completed
Start date
December 27, 2021
Completion date
August 3, 2022
Enrollment
230 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

endovascular procedure, hemostasis, peripheral vascular disease, vascular closure